A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2006
10/31/2006	US7129054 DNA sequences which code for new members of the TGF- beta protein family with mitogenic and/or differentiation-inductive potential
10/31/2006	US7129037 Delivering antigen to dendritic cells by contacting dendritic cells with apopototic cells expressing an antigen to allow antigen to be internalized by the dendritic cells, and wherein apoptotic cells have been induced in vitro to become apoptotic
10/31/2006	US7128921 Dermatophagoides proteins and fragments thereof
10/31/2006	US7128920 Isolated polypeptide and polynucleotide of given sequence; diagnosing or prognosing a disease by determining the presence or absence of a mutation in gene; Streptococcus pneumoniae
10/31/2006	US7128919 Comprising amino acid sequences of streptococcal matrix adhesion (Ema) polypeptides
10/31/2006	US7128918 Streptococcus antigens
10/31/2006	US7128917 Expression vector coding viral peptides for use in generating vaccine for prevention of viral diseases in fish hatcheries; aquaculture and fish farming
10/31/2006	US7128916 Bacteriophage-mediated immunisation
10/31/2006	US7128915 Membrane virus host range mutations and their uses as vaccine substrates
10/31/2006	US7128913 Erythropoietin conjugates
10/31/2006	US7128912 Fibronectin binding protein compositions and methods of use
10/31/2006	US7128911 Virus-like particle, and an antigen or antigenic determinant of a receptor activator factor kappa beta ligand protein, fragment or peptide
10/31/2006	US7128910 Moraxella catarrahalis outer membrane protein-106 polypeptide, gene sequences and uses thereof
10/31/2006	US7128909 For parenteral or mucosal administration of antigens and/or vaccines to humans and animals
10/31/2006	US7128908 Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof
10/31/2006	US7128907 Methods of treating crohn's disease with anti-TNF antibodies
10/31/2006	US7128906 T1 receptor-like ligand II and uses thereof
10/31/2006	US7128905 methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
10/31/2006	CA2336561C Monoclonal antibody to lymphocyte-associated cell surface protein
10/31/2006	CA2332183C Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use
10/31/2006	CA2293819C A method for in vitro molecular evolution of protein function
10/31/2006	CA2250047C Monoclonal antibodies binding human growth hormone (hgh)
10/31/2006	CA2243755C Streptococcal c5a peptidase vaccine
10/31/2006	CA2236925C Microencapsulated dna for vaccination and gene therapy
10/31/2006	CA2157376C Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
10/31/2006	CA2141410C Tetanus vaccine production
10/31/2006	CA2136953C A method for using lipoprotein associated coagulation inhibitor to treat sepsis
10/26/2006	WO2006113927A2 Immunogenic vaccinia peptides and methods of using same
10/26/2006	WO2006113909A2 Humanized anti-cd70 binding agents and uses thereof
10/26/2006	WO2006113792A2 Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
10/26/2006	WO2006113772A1 C. perfringens alpha toxoid vaccine
10/26/2006	WO2006113703A2 Carboline derivatives useful in the treatment of cancer
10/26/2006	WO2006113665A2 Covalent diabodies and uses thereof
10/26/2006	WO2006113648A2 Hn-33 compositions and methods
10/26/2006	WO2006113623A2 Elimination of heterogeneous or mixed cell population in tumors
10/26/2006	WO2006113622A2 Direct vaccination of the bone marrow
10/26/2006	WO2006113601A2 Leptospirosis culture process
10/26/2006	WO2006113594A1 Coccidial vaccine and methods of making and using same
10/26/2006	WO2006113546A2 Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
10/26/2006	WO2006113530A2 Selective inhibition of tlr4 signaling
10/26/2006	WO2006113528A2 Expressing hepatitis b virus surface antigen for vaccine preparation
10/26/2006	WO2006113526A2 Prevention of chlamydia infection using a protective antibody
10/26/2006	WO2006113483A2 Methods and compositions for treating or preventing cancer
10/26/2006	WO2006113402A1 Methods and compositions for modulating and detecting wisp activity
10/26/2006	WO2006113373A2 Novel vaccine formulations
10/26/2006	WO2006113372A2 Porcine circovirus and helicobacter combination vaccines
10/26/2006	WO2006113331A1 Methods for treating and preventing fibrosis by il-21 / il-21r antagonists
10/26/2006	WO2006113308A1 Method for treating inflammatory bowel disease (ibd) by an anti-cd20 antibody
10/26/2006	WO2006113214A2 Vaccine against pandemic strains of influenza viruses
10/26/2006	WO2006113209A1 Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
10/26/2006	WO2006113097A2 Methods of facilitating cell survival using neurotrophin mimetics
10/26/2006	WO2006112934A1 Photodynamic therapy utilizing multiple duty cycle light modulation
10/26/2006	WO2006112930A2 Q3 sparc deletion mutant and uses thereof
10/26/2006	WO2006112929A2 The hiv gp-41-membrane proximal region arrayed on hepatitis b surface antigen particles as novel antigens
10/26/2006	WO2006112869A2 Modulation of cytokine signaling regulators and applications for immunotherapy
10/26/2006	WO2006112838A1 Stabilized anti-hepatitis b (hbv) antibody formulations
10/26/2006	WO2006112556A1 Method for treating cancer using premedication
10/26/2006	WO2006112477A1 Polyamino acid for use as adjuvant
10/26/2006	WO2006112476A2 Biodegradable nanoparticle having antigen immobilized thereon and vaccine comprising the same
10/26/2006	WO2006112401A1 Composition for treatment of cancer
10/26/2006	WO2006111925A2 Inhibition of tumorigenesis by inhibition of a6b4 integrin
10/26/2006	WO2006111776A2 Pharmaceutical composition comprising serum obtained from a naive mammal
10/26/2006	WO2006111424A1 Methods for identifying modulators of cb1 and cb2 cannabinoid receptors and their use in wound healing
10/26/2006	WO2006111019A1 Mutant f. tularensis strain and uses thereof
10/26/2006	WO2006091209A3 Bispecific binding agents for modulating biological activity
10/26/2006	WO2006084694A3 Use of the mcm8 gene for the preparation of a pharmaceutical composition
10/26/2006	WO2006083984A9 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies
10/26/2006	WO2006076343A8 Mycobacteria expressing hiv-1 and malaria antigens
10/26/2006	WO2006073921A3 Compositions and methods for enhanced dendritic cell maturation and function
10/26/2006	WO2006063707A3 Novel pharmaceutical composition containing at least one dolastatin 10 derivative
10/26/2006	WO2006055331A9 Porcine reproductive and respiratory syndrome virus strains and compositions
10/26/2006	WO2006036203A3 Polyphosphazenes including ionic or ionizable moieties and fluorine-containing moieties
10/26/2006	WO2005079840A3 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
10/26/2006	WO2005074973A9 Method of inducing or modulating immune response
10/26/2006	WO2005067980A3 Design of therapeutics and therapeutics
10/26/2006	WO2005067460A3 Epha2 vaccines
10/26/2006	WO2005058940A3 Immunogenic peptide carrier conjugates and methods of producing same
10/26/2006	WO2005041891A3 Neutrophil activation by immune response modifier compounds
10/26/2006	WO2005020888A3 Compositions and methods of treating and diagnosing hepatoma
10/26/2006	WO2005011599A3 Antibodies specific for toxic amyloid beta protein oligomers
10/26/2006	WO2004078147A3 Oxytocin controlled release formulations and methods of using same
10/26/2006	US20060241291 Purified antibody, monoclonal antibody, or polyclonal antibody that binds to DES protein of Mycobacterium tuberculosis; medical diagnosis
10/26/2006	US20060241290 recombinant or monoclonal antibodies comprising the antigen-binding fragments specific for polypeptides, used for treating the effects of stroke, hypoxia and/or ischemia
10/26/2006	US20060241286 Novel peptides and the application thereof in therapy
10/26/2006	US20060241027 Hiv inhibiting proteins
10/26/2006	US20060240530 cDNA of a severe acute respiratory syndrome (SARS) coronavirus, recombinant SARS coronavirus vectors, and SARS coronavirus replicon particles
10/26/2006	US20060240512 Inducing oocyte activation by administering sperm perinuclear theca protein 34; interacts with tyrosine kinase; enhancing fertility; treating or diagnosing diminished fertility and abnormal spermiogenesis, providing contraception; identifying contraceptive and fertility-enhancing agents
10/26/2006	US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/26/2006	US20060240482 Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
10/26/2006	US20060240466 Prevention of Type 1 diabetes and other non-polio enterovirus diseases
10/26/2006	US20060240464 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
10/26/2006	US20060240446 Novel human cytomegalovirus DNA sequences
10/26/2006	US20060240436 Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar)
10/26/2006	US20060240422 Caspase 10 as target for monitoring and treatment of diseases
10/26/2006	US20060240414 Genetically engineered glutaminase and its use in antiviral and anticancer therapy
10/26/2006	US20060240092 Polymeric micelles for drug delivery
10/26/2006	US20060240047 Method for producing a vaccine for the treatment of cancer
10/26/2006	US20060240046 Live attenuated Leishmania vaccines
10/26/2006	US20060240045 Neisserial vaccine compositions comprising a combination of antigens
10/26/2006	US20060240044 Streptococcal superantigens spe-l and spe-m

1 ... 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 ... 1823